The Claim

Among patients with acute coronary syndrome, baseline low-density lipoprotein cholesterol (LDL-C) levels below 55 mg/dL are associated with a 51% higher adjusted risk of major adverse cardiac and cerebrovascular events within one year compared to higher LDL-C levels, despite more intensive lipid-lowering therapy, and this association persists after adjustment for age, prior cardiovascular disease, diabetes, kidney function, and inflammation.

Source: Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Patients with acute coronary syndrome who have very low LDL cholesterol levels below 55 mg/dL experience 51% more major heart and brain events within one year than those with higher LDL levels, even when receiving stronger cholesterol-lowering treatment.

See the scientific wording

Among patients with acute coronary syndrome, those with baseline low-density lipoprotein cholesterol (LDL-C) levels below 55 mg/dL have a 51% higher adjusted risk of major adverse cardiac and cerebrovascular events (MACCE) within one year compared to those with higher LDL-C levels, despite being on more intensive lipid-lowering therapy; this association persists after adjusting for age, prior cardiovascular disease, diabetes, kidney function, and inflammation, suggesting that very low LDL-C in this population reflects advanced atherosclerotic burden rather than inadequate treatment.

Why this might work

Years of cholesterol buildup in artery walls create large, unstable plaques that are prone to rupture. Even when cholesterol levels are very low, these damaged arteries still have deep scars and inflamed tissue that can suddenly block blood flow, causing heart attacks or strokes.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study

    People who’ve had a heart attack and already have very low cholesterol are more likely to have another heart or brain problem—not because their medicine is too strong, but because their heart disease is already very bad and has been going on for a long time.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.